|
|
Post by factspls88 on Dec 18, 2017 10:29:30 GMT -5
These declines are brutal, especially in the face of everything else going up. I'm hanging in but this is getting ridiculous. C'mon Mike C, let's see some tangible, positive results.
|
|
|
|
Post by xoxoxoxo on Dec 18, 2017 10:38:23 GMT -5
Ah yes, the 9% drop for no reason on no news just for funsies. In the olden days we thought this was just shaking out the weak hands before the upside began. But now, we know the true reason of the decline was me buying back in around $3.67. MNKD is the fastest way to achieve a -30% return in an up market. Sure, let's throw some more money at it just because we hate seeing big percentage declines in our portfolio and can mitigate it by averaging down.
The great lesson that I truly appreciate from MNKD is to quit investing in individual stocks and learn to love your passive vanguard index funds. Thanks Al!
|
|
|
|
Post by kbrion77 on Dec 18, 2017 10:43:18 GMT -5
If you think this is bad what will happen if/when they don't come in at the bottom end of their Q4 projections? It is games today by the end of the day it will probably close -4% but the next couple weeks could get bad if there are no new updates, Q4 sales miss as well as an earnings miss.
|
|
|
|
Post by pantaloons on Dec 18, 2017 10:50:02 GMT -5
The timing of approval for authorized shares seems bizarre.
For some reason, MNKD management felt that risk/benefit profile was favorable to vote/authorize shares, specifically at this time, without any material news that would support share price - the leverage of these authorized shares are only as useful as the market price of them.
If no news is released anytime soon, this will not set a very good precedent for the company's future. Would be interested in hearing others' opinions about this.
|
|
|
|
Post by Clement on Dec 18, 2017 10:51:04 GMT -5
This morning, I entered buy orders for a price just a wee bit lower than right now. I'm buying more!
|
|
|
|
Post by madog365 on Dec 18, 2017 10:57:17 GMT -5
I believe short sellers are basically calling all Castagna's promises a bluff, continuing to add to their positions and reinforcing their beliefs the company is failing. The only way the bleeding stops is with concrete news on multiple efforts including additional recapitalization, international partnership, and next steps with one drop and receptor - or significantly higher growth in scripts than what we are seeing today.
Many including myself thought there would news coming out of the authorization vote. That has not happened yet - and if Mike really has nothing else to say than what is happening is a totally fair reaction.
|
|
|
|
Post by timri on Dec 18, 2017 10:58:33 GMT -5
I’m pretty sick of threads like this over the last 5 years. Why can’t we have a sustained Gains and cut this manipulation crap out.
|
|
|
|
Post by slugworth008 on Dec 18, 2017 11:06:12 GMT -5
These declines are brutal, especially in the face of everything else going up. I'm hanging in but this is getting ridiculous. C'mon Mike C, let's see some tangible, positive results. Yep, the brutality continues on the trail of tears known as MNKD. I remain optimistic but am so weary of the continued beatdown in my portfolio. |
|
|
|
Post by lojothehus on Dec 18, 2017 11:12:54 GMT -5
These declines are brutal, especially in the face of everything else going up. I'm hanging in but this is getting ridiculous. C'mon Mike C, let's see some tangible, positive results. Yep, the brutality continues on the trail of tears known as MNKD. I remain optimistic but am so weary of the continued beatdown in my portfolio. I will say this about MNKD. Whenever we get to the end of all of this misery; however it turns out, you will have think that you earned every penny from your investment whatever amount it may be, or you will have to accept the torment and feel a bit relieved because it will all be over. I cannot understand though, why Mike C is making moves without having something concrete to immediately follow. If you give the shorts the ball field, they are going to play on it. |
|
|
|
Post by factspls88 on Dec 18, 2017 11:17:26 GMT -5
I’m pretty sick of threads like this over the last 5 years. Why can’t we have a sustained Gains and cut this manipulation crap out.A A little venting never hurt anyone. There's plenty of positive commentary here, including from yours truly from time to time. |
|
|
|
Post by seanismorris on Dec 18, 2017 11:27:40 GMT -5
This is likely about taxes.
As I said previously, why not sell and buy back in in January?
I don’t see any positive news near term, and scripts aren’t likely to jump until next year...
Personally I don’t have any reason to sell, but the market is crazy high. If someone wants to take profits, selling MNKD will help.
Also, this is also about politics. The tax bill is unlikely to have effect that the markets have built in.
People should sell the news, and there is to much risk going into the holidays with the hedgies not at their desks.
|
|
|
|
Post by wmdhunt on Dec 18, 2017 11:37:38 GMT -5
Could it be end of year tax loss selling? Whatever it is, we are hurt again...
|
|
|
|
Post by xanet on Dec 18, 2017 11:39:21 GMT -5
And Looking for Diogenes unleashes what may be his strongest hit piece to date, declaring inhaled insulin dead. I won't justify it with a link. The outlook for Afrezza is bright IMO. Management has bought time with the authorization vote. They admittedly are not caught up in fretting over the day to day share price volatility, nor should they be. There are bigger things at stake. Once those are settled, share price will take care of itself. No, I am not predicting any imminent news, nor do I expect it. This is a high risk stock which I invest in because I believe in the product and hope for its success and for future gains. Emphasis on future. :-)
Edited to correct from SO to LFD.
|
|
|
|
Post by celo on Dec 18, 2017 11:39:47 GMT -5
The yield curve is flattening and a recession/stock market dip would soon follow if the curve becomes inverted. The market flying as high as it is, I think is setting itself up for some downside in the spring.
|
|
|
|
Post by casualinvestor on Dec 18, 2017 11:44:06 GMT -5
I believe short sellers are basically calling all Castagna's promises a bluff, continuing to add to their positions and reinforcing their beliefs the company is failing. The only way the bleeding stops is with concrete news on multiple efforts including additional recapitalization, international partnership, and next steps with one drop and receptor - or significantly higher growth in scripts than what we are seeing today. Many including myself thought there would news coming out of the authorization vote. That has not happened yet - and if Mike really has nothing else to say than what is happening is a totally fair reaction. Yeah, I can see shorts thinking about upcoming dilution (although, as far as I know, MNKD still has ~6 months of cash on hand) as an easy way to close out a larger short position. Probably index funds are making more shares available to short with cheaply, right now. Todays decline comes with higher volume. Short are borrowing and selling. We'll see if the cost to borrow goes up at all. I'm sure Mike C is aware of all this, but whether he has the good news to combat this is another story. And even if he does, now might not be the right time. Regional ads probably need more time to take effect in actual sales. Early reporting of half-baked results could do more harm than good. Same with the STAT study, or TREP-T progress, or whatever. I think we're in for a slow decline until there is good news. Although the low PPS may make the stock attractive all by itself. But the only good news I think we might see in the near future is Friday's scripts. I don't see anything coming from MNKD until Jan. But I don't even have a crystal ball, much less any inside info |
|
